Job Watch

SRG: Data Analyst - Science

New Scientist - Bioinformatics - Thu, 2021-02-04 11:12
Excellent Benefits: SRG: Analysis of NGS data throughout the research and development of novel molecular diagnostic instruments. London, England
Categories: Job Watch

We paused our Ph.D. research to lead a COVID-19 contact tracing team. Here’s what we learned

Graduate training prepares students for much more than research, these Ph.D. students write
Categories: Job Watch

High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed)

Funding Opportunity RFA-DA-22-006 from the NIH Guide for Grants and Contracts. This FOA will support high-throughput screening or similar transformative approaches to identify novel receptors, signal transducers, or small molecules that modulate SUD-relevant signal transduction pathways (dopamine, opioid, cannabinoid, nicotinic, or other appropriately justified pathway). These projects may also include secondary screens and/or validation of key hits identified.

Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required)

Funding Opportunity RFA-AG-22-011 from the NIH Guide for Grants and Contracts. NIA invites applications for Phase 1, 2a, and 2b clinical trials of new compounds or re-purposed existing drugs, biologics (except stem cells), or supplements to treat multiple chronic conditions by modulating fundamental aging-related mechanisms as well as to test compounds that could affect the individual diseases and conditions disproportionally affecting older adults. This FOA is not intended to provide support for definitive efficacy and safety trials.

Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)

Funding Opportunity PA-21-158 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.

Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)

Funding Opportunity RFA-TR-21-009 from the NIH Guide for Grants and Contracts. This FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e. scents or odors) emanating from skin and to develop a catalog of VOCs as distinct signatures for at least 20 human diseases and conditions. These sensing devices must be able to associate VOC patterns using artificial intelligence to patients with various conditions for diagnostic purposes along with capabilities to incorporate and integrate vital signs. For VOC monitoring, these sensing devices can be Electronic-nose (E-nose) technology, Gas Chromatography (GC) or any sensing technology able to detect VOC patterns associated with disease. This new program is called SCENT, which stands for Screening for Conditions by E-Nose Technology. To ensure project success, this FOA requires multidisciplinary collaborations and a team science approach. Groups may include a combination of the following: Biomedical engineers, material scientists, biosensing experts, software engineers, chemists, clinicians, clinical trialists, biostatisticians, data analysts and/or other relevant experts in academia and industry.

Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded research

Notice NOT-LM-21-005 from the NIH Guide for Grants and Contracts

Request for Information (RFI): Screening for High Resolution Cryo-Electron Microscopy

Notice NOT-RM-21-012 from the NIH Guide for Grants and Contracts

What we’ve learned from communicating our science during the pandemic

"Feel free to speak passionately about why the science matters to you," our Letters to Young Scientists columnists write
Categories: Job Watch

Paramount Recruitment: Scientific Software Developer

New Scientist - Bioinformatics - Tue, 2021-02-02 15:41
Negotiable: Paramount Recruitment: Scientific Software Developer Paramount have partnered with a major new start up in Oxford that has made exceptional progress in the field of canc Homeworking
Categories: Job Watch

How to showcase your department to prospective grad students—virtually

Virtual “visits” can provide valuable insight—as long as they’re planned strategically
Categories: Job Watch

EMBL: Head of Human Resources, EMBL-EBI

New Scientist - Bioinformatics - Tue, 2021-02-02 04:36
Competitive Salary: EMBL: Head of Human Resources, EMBL-EBI Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch